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Abstract: The transcription factor SOX2 is important for brain development and for neural stem
cells (NSC) maintenance. Sox2-deleted (Sox2-del) NSC from neonatal mouse brain are lost after
few passages in culture. Two highly expressed genes, Fos and Socs3, are strongly downregulated in
Sox2-del NSC; we previously showed that Fos or Socs3 overexpression by lentiviral transduction fully
rescues NSC’s long-term maintenance in culture. Sox2-del NSC are severely defective in neuronal
production when induced to differentiate. NSC rescued by Sox2 reintroduction correctly differentiate
into neurons. Similarly, Fos transduction rescues normal or even increased numbers of immature
neurons expressing beta-tubulinIII, but not more differentiated markers (MAP2). Additionally, many
cells with both beta-tubulinIII and GFAP expression appear, indicating that FOS stimulates the initial
differentiation of a “mixed” neuronal/glial progenitor. The unexpected rescue by FOS suggested that
FOS, a SOX2 transcriptional target, might act on neuronal genes, together with SOX2. CUT&RUN
analysis to detect genome-wide binding of SOX2, FOS, and JUN (the AP1 complex) revealed that
a high proportion of genes expressed in NSC are bound by both SOX2 and AP1. Downregulated
genes in Sox2-del NSC are highly enriched in genes that are also expressed in neurons, and a high
proportion of the “neuronal” genes are bound by both SOX2 and AP1.
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1. Introduction
The SOX2 transcription factor is expressed in the central nervous system (CNS) from
the earliest developmental stages throughout vertebrate evolution [1,2]. Heterozygous
loss-of-function mutations of SOX2 in humans lead to a spectrum of CNS abnormalities,
including vision defects, hippocampal defects, and intellectual disability, pointing to important functions in many aspects of neurodevelopment [1,2]. In mice, SOX2 functional roles in
the CNS have been demonstrated by Sox2 hypomorphic mutants as well as by conditional
Sox2 knockouts [3–6]. At the cellular level, SOX2 was found to play an essential function
in the maintenance of neural stem cells (NSC) in the developing CNS and, postnatally, in
both the lateral ventricle (LV) and hippocampus dentate gyrus (DG) [3,5,7]. A requirement
for Sox2 in the long-term maintenance of brain-derived NSC grown in vitro was confirmed
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by additional studies [3,8,9]. On the other hand, the terminal differentiation of NSC into
neurons was also found to require Sox2. Indeed, GABAergic neurons migrating during
development from the ganglionic eminence towards the cortex are abnormal in Sox2 mutants [10]. Further, in the postnatal hippocampus, partial Sox2 deficiency in mice that are
compound heterozygous for hypomorphic and null Sox2 alleles resulted in a decreased in
the fraction of proliferating (BrdU-positive) NSC that give rise to terminally differentiated
neurons [5]. Accordingly, NSC from such hypomorphic Sox2-mutant brains and cultured
in vitro in differentiating conditions, display a specific impairment in the production of
terminally differentiated neurons; this defect is rescued by lentiviral transduction of Sox2
at early (but not late) stages of in vitro differentiation [10]. A role for SOX2 in neuronal
differentiation was also documented in mice, in projection neurons of the visual thalamus,
which require SOX2 for their maturation and the establishment of appropriate connectivity
with the retina and cerebral cortex [11]. Finally, a neuronal differentiation function for
SOX2 was suggested to occur in different species, such as C. elegans [2].
The functional involvement of SOX2 in neuronal differentiation raises the question of
which downstream genes mediate this function, and of which molecular mechanisms are
involved. In this work, we report that Fos, one of the genes most downregulated in NSC
following Sox2 neural conditional knockout [8], is able, when introduced into Sox2-deleted
NSC via a lentiviral vector, to substantially rescue their neuronal differentiation defect.
Gene ontology analysis of RNA-seq data highlights that the most represented functional
category among genes downregulated in Sox2-deleted versus wild-type NSC is represented
by genes involved in neuronal differentiation. Strikingly, CUT&RUN analysis of FOS,
JUN (together forming the AP1 complex), and SOX2 in NSC chromatin reveals a broad,
genome-wide co-binding of SOX2 and AP1 to neuronal differentiation genes expressed in
NSC. This suggests the interesting possibility that neuronal differentiation is set in motion
by a gene regulatory network jointly regulated by SOX2 and AP1.
2. Materials and Methods
2.1. Primary Ex-Vivo Neural Stem/Progenitor Cell Cultures
Brain-derived NSC cultures were obtained from dissected telencephalon of wildtype and Sox2-deleted P0 mice [3,8] and grown in fresh medium (FM): DMEM-F12 with
Glutamax (GIBCO, Milan, Italy), supplemented with 1/50 v/v B27 (Life Technologies,
Milan, Italy), 1% of penicillin-streptomycin (Euroclone, Milan, Italy) supplemented with
EGF (10 ng/mL, Tebu-bio, Milan, Italy) and bFGF (10 ng/mL, Tebu-bio, Milan, Italy) as a
mitogen, as described in [3,8,9,12].
2.2. RNA-seq
RNA-seq data for undifferentiated (differentiation day 0, D0) normal (WT), and Sox2deleted (Sox2-del) NSC were previously reported [8]. RNA-seq analysis of the same
cells (three WT, three Sox2-del populations, see Table 1) at D4 and D11 of differentiation
was performed in parallel to the D0 analysis in exactly the same way as for D0. D4 and
D11 RNA-seq raw data were processed, from expression quantification to differential
expression analysis, following the same pipeline described in [8] for D0. Expression data,
false discovery rate (FDR), and fold-change (FC) values are available in Table S1. Raw data
can be found under accession number GEO: GSE90561.
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Table 1. Levels of Fos (A), Socs3 (B), and Sox2 (C) mRNA, in wild-type and Sox2-del cells during NSC
differentiation (D0, D4, D11). Three wild-type (WT) and three Sox2 mutant (Sox2-del) mice were used
to generate NSC cultures that were then analyzed at D0, D4, and D11 by RNA-seq. TPM, transcripts
per million. D0 values are from our previous work [8]; D4 and D11 genome-wide RNA-seq data are
reported in Table S1. The slight increase of the ratio of Sox2 mRNA in Sox2-del versus WT at D4 and
D11 might be due to preferential proliferation at early stages of differentiation, or better survival, of
rare Sox2-positive cells present at P0.
Fos (TPM Values)
WT

Sox2-del

Mouse number

1

2

3

1

2

3

D0

3430.60

2984.97

2189.25

978.08

259.14

1218.42

D4

14.52

4.38

7.48

5.28

4.92

4.81

D11

22.80

58.71

32.46

29.79

64.64

35.61

Socs3 (TPM Values)
WT
Mouse number
D0

1
235.80

Sox2-del

2

3

1

2

3

336.16

191.33

27.50

11.18

49.28

D4

9.65

4.29

4.33

3.30

3.69

1.13

D11

20.20

19.08

21.81

41.68

50.67

44.26

Sox2 (TPM Values)
WT

Sox2-del

Mouse number

1

2

3

1

2

3

D0

495.40

306.24

247.93

2.59

6.64

3.45

D4

332.73

151.27

307.37

5.00

21.53

8.02

D11

200.03

224.55

242.31

11.84

26.34

17.22

2.3. Lentiviral Constructs
The Fos expressing lentivirus was previously described in [9]: the Fos cDNA was
cloned into a unique BamHI site upstream to the IRES-dNGFR cassette of the pHR SIN
BX IR/EMW [13] (provided by A. Ronchi, Milan, Italy). The Sox2 and Socs3-expressing
lentiviruses were previously described [3,8,9] and also expressed the GFP fluorescent marker.
Lentiviral vectors were produced by calcium phosphate transfection into the packaging human embryonic kidney cell line 293T, of the VSV-G plasmid (encoding ENV),
CMV R8.74 (packaging), and pRSV-REV (encoding reverse transcriptase) [8,9,13]. Briefly,
after transfection, following replacement with DMEM high glucose (Euroclone, Milan,
Italy), containing 10% fetal bovine serum (Sigma, Milan, Italy), 1% penicillin-streptomycin
(Euroclone, Milan, Italy), 1% of L-glutamine (Euroclone, Milan, Italy), the cell supernatants
were collected 72 h after transfection. Lentiviral vectors were titrated on HEK-293T cells
by measuring the percentage of eGFP (for the Sox2 and Socs3-transducing vectors) and of
dNGFR-positive cells (for the Fos-transducing vector) by flow cytometry [9,13].
2.4. Sox2-del Transduction with Lentiviral Constructs Encoding Sox2, Socs3 and Fos
Sox2-del NSC transduction with lentiviral constructs, expressing Sox2, Fos, or Socs3,
was as in [8,9,14]. After 6–8 passages in NSC proliferation medium [8,9], during which
essentially all cells had become positive for the virally transduced Sox2, or Fos, or Socs3
expression construct [8,9], cells were induced to differentiate.
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2.5. RT-PCR Analysis of Sox2, Fos, and Socs3
The RT-PCR analysis of Sox2, Fos, and Socs3 in Figure S4 was performed as in [9]. The
primers used for Socs3 and Fos mRNA detection were as in [9]; primers for Sox2 mRNA
detection were:
Sox2_Fw GGCAGCTACAGCATGATGCAGGAGC;
Sox2_Rev CTGGTCATGGAGTTGTACTGCAGG.
Sox2-del NSC transduced with Sox2, or Fos, or Socs3 expression vectors and kept in
culture for more than eight passages were analyzed in parallel with WT NSC and Sox2-del
NSC at early (4–6) passages.
2.6. NSC Differentiation
Sox2-del NSC transduced with Sox2, or Fos, or Socs3 expression vectors were kept
in long-term culture and differentiated after 6–8 passages or later, when most of the NSC
appeared to harbor the transduced vector [8,9]. Sox2-del NSC were differentiated before
passage 6, when they were still efficiently growing. NSC differentiation was as in [10].
Briefly, WT, Sox2-del, Sox2-del + Sox2, Sox2-del + Fos, and Sox2-del + Socs3 NSC were
dissociated to single cells, and plated onto MATRIGEL (Becton Dickinson, NJ, USA) coated
glass coverslips at 4 × 104 cells/1 mL/well in 24-well plates in FM with bFGF only as the
mitogen [10]. After 4 days, the medium was changed to neural stem cell medium without
bFGF, supplemented with 1% embryonic stem-cell FBS (Thermo Fisher, Milan, Italy). After
a further seven days (differentiation day 11), cells were analyzed by immunocytochemistry.
2.7. Immunocytochemistry
At differentiation day 11, cells were fixed (20 min) with 4% PFA in phosphate-buffered
saline (PBS; pH 7.4) and rinsed three times with PBS. Coverslips were then incubated
for 90 min at 37 ◦ C in PBS containing 10% normal goat serum (NGS), 0.2% Triton X-100.
Coverslips were incubated with the primary antibodies overnight at 4 ◦ C. Following
thorough washing with PBS, cells were incubated for 45 min (room temperature) with
specific secondary antibodies (1:1000, AlexaFluor Invitrogen, Milan, Italy). Coverslips were
rinsed three times in PBS and mounted on glass slides with Fluoromount (Sigma, Milan,
Italy) with DAPI (40 ,6-diamidino-2-phenylindole).
Primary antibodies:
anti-β-TubIII (rabbit polyclonal IgG, 1:400, Covance, NJ, USA),
anti-MAP2 (mouse monoclonal IgG1, 1:100 Merck, Darmstadt, Germany),
anti-GFAP (mouse monoclonal IgG1, 1:100 Merck, Darmstadt, Germany),
Secondary antibodies:
goat anti-rabbit IgG 488 AlexaFluor (1:1000, Invitrogen, Milan, Italy),
goat anti-mouse IgG1 594 AlexaFluor (1:1000, Invitrogen, Milan, Italy).
2.8. GO Enrichment Analysis
Published RNA-seq data and a list of differentially expressed genes from wt and
Sox2-deleted NSCs were downloaded from [8] (GEO accession number GSE90561). The
biological functions of downregulated genes were investigated by gene ontology (GO)
enrichment using the online tool WebGestalt (WEB-based Gene SeT AnaLysis Toolkit3 ) [15];
over-representation analysis (ORA) on biological processes was performed using as a
reference set the list of genes overall expressed by either wt or Sox2-deleted NSCs. Only
categories with a gene number between 100 and 2000 were considered, and the multiple
test adjustment method was set to Benjamini–Hochberg (BH); other parameters were
set as default. For further analyses, genes belonging to GO terms inherent to neuronal
differentiation, development, maturation, function, and maintenance were extrapolated.
2.9. CUT&RUN
Raw reads were taken from our previously published datasets (ArrayExpress accession
E-MTAB-9897) and trimmed using bbDUK (Bbtools-BBMap-BushnellB.-sourceforge.net/
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projects/bbmap/). Trimmed reads were mapped to the mm10 genome using bowtie [16],
with the settings -I 80 -X 400 -m 1 -v 3. Samtools [17] was used to create bamfiles, including
a set of files mapping at or below 120 basepairs (“subnucleosomal reads”). Bedgraphs
were created using bedtools [18]. Bedtools was also used to remove blacklisted regions.
Peaks were called using SEACR [19] in relaxed mode, normalizing to negative control
tracks. To create a stringent set of peaks, peaks from individual subnucleosomal tracks
were intersected with consensus peaks from either AP1 and SOX2 and collected into a
single track. Overlapping peaks were extracted using bedtools. Motifs underlying all
peaks, and subnucleosomal peaks, were found using HOMER [20] using the masked mm10
genome and options -size given and -cpg. Peaks were annotated using GREAT [21], using
default settings (basal plus extension mode). Lists of annotated peaks were intersected
with RNA-seq data from [8]. Genes downregulated upon knockout of SOX2 were extracted
using log2-fold change -1. STRING-db [22] was used to create interaction graphs of genes.
Only edges found in experiments and databases at a confidence level of 0.5 were kept. The
proteins annotated with GO term neuron differentiation in the largest consecutive cluster
were extracted and re-graphed, allowing coexpression.
3. Results
3.1. Lentiviral Expression of Sox2 in Sox2-Deleted NSC Rescues Their Ability to Generate
Neurons upon Induction of Differentiation
Sox2-deleted (Sox2-del) NSC, obtained from neonatal mice by Sox2 conditional deletion in vivo via Nestin-Cre [3], progressively loses the ability to self-renew as undifferentiated cells in in vitro culture, within about 5–9 passages [3]. We performed RNA-seq
experiments, comparing three wild-types (WT) and three Sox2-deleted (Sox2-del) NSC
cultures derived from independent mice; we performed the experiment at early passages,
when growth kinetics of WT and Sox2-del were still similar. This analysis revealed a
significant decrease in the expression of about 1000 genes in Sox2-del cells [8]. In Sox2-del
NSC, Socs3 and Fos mRNAs are strongly and highly significantly downregulated in the
undifferentiated state (differentiation day 0, D0), as compared to their high expression in
WT cells (Table 1) [8,9]. As Socs3 and Fos mRNA re-expression in Sox2-deleted cells via
viral transduction rescues long-term self-renewal [8,9], it is possible to obtain viable NSC
populations lacking Sox2; this gives us the opportunity to examine the role of FOS and
SOCS3 in cell differentiation.
Upon induction of in vitro NSC differentiation of the same cell cultures analyzed
at D0, both Socs3 and Fos mRNAs are strongly downregulated, in both WT and Sox2del cells, at differentiation day 4 (D4) as measured by RNA-seq (Table 1); subsequently,
upon addition of serum and mitogen removal at D4, the levels of Socs3 and Fos are again
moderately increased at D11. At D4 and D11, Fos mRNA levels were not significantly
different between WT and Sox2-del NSC (FDR: 0.14 at D4, >0.2 at D11); Socs3 mRNA levels
did not significantly differ between WT and Sox2-del NSC at D4 (FDR: 0.09), but were
slightly, and significantly, upregulated in Sox2-del NSC at D11 (FDR: 0.0006). In parallel,
Sox2 expression in WT NSC progressively slightly decreased between D0 and D11, by
about 30% (Table 1).
We first tested in vitro differentiation to neurons and glia of WT and Sox2-del cells
(Figure 1 and Figure S1). Morphological and immunofluorescence analysis demonstrated
that, in differentiated Sox2-del cells, the proportion of neuronal cells (as identified by
extended neurites and beta-tubulinIII positivity) was strongly decreased (Figure 1A,B,D).
MAP2 positivity, marking more mature neuronal cells, was absent in Sox2-del cells, although it was present in control WT cells (Figure 1A,B,F). In contrast to the neuronal
population, glial cells, marked by GFAP expression, displayed a normal morphology in
Sox2-del cells. The proportion of glial cells was increased in Sox-del cells, mirroring the
decrease in the proportion of neuronal cells (Figure 1A,B,E). These results are reminiscent
of those obtained by Cavallaro et al. [10], using NSC from a Sox2 hypomorphic mutant,
expressing approximately 30% of the normal (wild type) Sox2 level.
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Figure 1. Sox2 deletion impairs neuronal differentiation of NSC, and this is rescued by lentiviral Sox2
re-expression. (A) Immunofluorescence (IF) for β-tubulinIII, a neuronal marker, GFAP, a glial marker,
and MAP2, a marker of mature neurons in WT cells at D11. Top: β-tubulinIII positive cells show
long arborizations and mature neuronal morphology. Bottom: all β-tubulinIII positive cells are also
MAP2 positive. (B) IF for β-tubulinIII, GFAP and MAP2 IF in Sox2-del cells at D11. IF shows few
β-tubulinIII positive cells with an immature morphology; some cells also show β-tubulinIII/GFAP
double positivity. MAP2-positive cells are absent. (C) β-tubulinIII, GFAP, and MAP2 IF in Sox2transduced Sox2-del cells (Sox2-del + Sox2) at D11. (D–F) Histograms show the percentage of cells
positive for β-tubulinIII, GFAP and MAP2, respectively, compared to the total cell number. (G)
Histograms show the percentage of MAP2-positive cells/β-tubIII-positive cells. (D,E) Results are the
mean of counting 16–20 fields in each of n = 7 independent differentiation experiments conducted on
3 different WT samples (from 3 WT mice) and 3 different Sox2-del samples (from 3 Sox2-del mice);
(F,G) Results are the mean of 16–19 fields counted in n = 2 independent differentiation experiments,
each conducted on two WT and two Sox2-del samples. Statistical significance was assessed by Brown
1Forsythe ANOVA and Dunnet T3 test (**** p < 0.0001; ns: not significant).

We then re-expressed Sox2 in Sox2-del NSC via a lentiviral vector (Figure S2), rescuing
long-term growth and generating a population that expresses Sox2 in almost all NSCs [9].
When these Sox2-transduced, Sox2-del NSC were differentiated as described above, the
number of neurons obtained at D11 returned to essentially normal levels, when compared
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to WT cells (Figure 1A–D). In addition, their morphology appeared to recover “maturity”,
as indicated by arborization and MAP2 positivity (Figure 1A–C,F,G); the number of “mature” cells in the Sox2-transduced, Sox2-del cells fully recovered the numbers seen in WT
cells (Figure 1D,F,G). The proportion of glial cells in Sox2-del Sox2-transduced cells was
significantly reduced in comparison to Sox2-del cells as expected, due to the increased
proportion of neuronal cells caused by Sox2 transduction, and possibly also to some defect
in gliogenesis (Figure 1A–C,E); indeed, SOX2 acts as a GFAP repressor in cotransfection experiments [10]. These results confirm and extend the ability of SOX2 to rescue the defective
neuronal maturation observed in Sox2-deficient hypomorphic NSC [10].
3.2. Lentiviral Expression of Fos in Sox2-del NSC Rescues Their Ability to Generate Neurons upon
Induction of Differentiation
Fos expression is strongly reduced in Sox2-del NSC, and Fos is a direct target of
SOX2 itself [8,9]. Of note, we have previously shown that Fos expression by lentiviral
transduction rescues long-term self-renewal of undifferentiated Sox2-del NSC [9]. We
obtained populations of Fos-transduced Sox2-del cells (Figure S2), which, after 6–7 passages,
mostly consisted of lentivirally transduced cells, presumably due to positive selection for
Fos expression. As Fos is downstream to SOX2, we asked whether Fos might be a mediator
of the SOX2-induced rescue of neuronal generation shown in Figure 1, by studying the
differentiation of Fos-transduced Sox2-deleted NSC. Figure 2 shows that, indeed, Fos
induces a strong increase in the number of cells expressing the beta-tubulin III neuronal
marker, even exceeding (up to 40–50%) the proportion of beta-tubulin-III-positive cells
observed in WT cells (Figure 2A–C,E,F); conversely, the fraction of GFAP-positive cells was
moderately decreased (Figure 2G). Importantly, when stained both with anti-GFAP and
with anti-beta-tubulin-III antibodies, many cells showed a double positivity (Figure 2A,B),
so that the number of beta-tubulin-III-positive plus GFAP-positive cells was well above
the total number of cells (Figure 2E). Interestingly, MAP2 staining was not observed in
Sox2-del, Fos-transduced differentiated cells (Figure 2C,I). Looking at cell morphology,
most cells positive for beta-tubulin III showed a neuronal appearance, similar to that
seen with WT cells, whereas the majority of doubly stained (beta-tubulin + GFAP) cells
had a poorly defined morphology, neither clearly neuronal nor glial (Figure 2B). Overall,
these results indicate that Fos overexpression was able to stimulate the initial neuronal
differentiation of bipotent neuronal/glial progenitors, but fails to induce a more advanced
neuronal differentiation program, with the appearance of mature neuronal markers (MAP2)
and complete extinction of GFAP expression.
3.3. Lentiviral Expression of Socs3 in Sox2-del NSC Inhibits the Genesis of Glial Cells upon
Induction of Differentiation
Socs3 expression is extremely reduced in Sox2-del NSC; re-expression of Socs3 by
lentiviral transduction (Figure S2) allows Sox2-del NSC to maintain long-term
self-renewal [8]. We induced differentiation of long-term proliferating Socs3-transduced,
Sox2-del NSC: this resulted in a dramatic decrease of glial cells, as indicated by morphological observations and GFAP staining (Figure 3A,B). As in Sox2-del cells (Figure 1), the
number of well-differentiated neurons was strongly decreased (Figure 3B,C); note, however, that a large number of weakly beta-tubulin-III-positive cells, not resembling neurons,
were detected in Socs3-transduced Sox2-del cells. We conclude that Socs3 overexpression
antagonizes glial differentiation, but is unable to rescue neuronal differentiation; the high
number of beta-tubulin-III-positive cells observed in Sox2-del cells transduced with Socs3
might represent bipotent glial/neuronal progenitors that are arrested at a very early stage
of differentiation, before resolving their fate into either neuron or glia (due to the combined
effect of lack of Sox2 and inhibition of gliogenesis by Socs3).
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Figure 2. Lentiviral expression of Fos in Sox2-deleted NSC rescues their ability to generate neurons upon induction of

Figure 2. Lentiviral expression of Fos in Sox2-deleted NSC rescues their ability to generate neurons upon induction of
differentiation. IF for β-tubulinIII, GFAP, and MAP2 in Fos-transduced Sox2-del cells (Sox2-del + Fos) at D11. (A) Fos
differentiation.
IF for β-tubulinIII,
GFAP, and into
MAP2
in Fos-transduced
Sox2-del
cells
(Sox2-del
+ for
Fos)
at βD11. (A) Fos
overexpression
rescues the differentiation
neurons
(β-tubulinIII-positive
cells); some
cells
are positive
both
tubulinIII
and GFAP
(orange arrows), into
and some
β-tubulinIII-positive
cells have a somewhat
“glial”cells
morphology
(green for both βoverexpression
rescues
the differentiation
neurons
(β-tubulinIII-positive
cells); some
are positive
arrows). (B) Double-positive cells have different morphologies: top panel, glial-like cells; middle panel, neuronal-like cells;
tubulinIII and GFAP (orange arrows), and some β-tubulinIII-positive cells have a somewhat “glial” morphology (green
arrows). (B) Double-positive cells have different morphologies: top panel, glial-like cells; middle panel, neuronal-like cells;
bottom panel, poorly defined morphology. (C,D) Absence of MAP2 staining in Sox2-del, Fos-transduced differentiated cells.
(E) Histograms show the percentage of differentiated cells out of the total; in the Sox2-del + Fos population the total % of
β-tubIII + GFAP-positive cells is greater than 100%, indicating the existence of double-positive cells. (F,G) Percentage of
β-tubIII, GFAP, and MAP2-positive cells/total cell number. (H) Percentage of double-positive cells/total cell number in
Sox2-del, Sox2-del + Sox2, and Sox2-del + Fos samples. Fos overexpressing cells often show double positivity for β-tubIII
and GFAP. (I) Percentage of MAP2-positive cells/β-tubIII-positive cells. Results are the mean of 16–20 fields counted in
n = 2 independent differentiation experiments. Statistical significance was assessed by Brown Forsythe ANOVA and Dunnet
T3 test (**** p < 0.0001; *** p < 0.001; ** p < 0.01; ns: not significant).
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3.4. RNA-seq Demonstrates That Genes Downregulated in Undifferentiated Sox2-del NSC Are
Enriched in Genes Involved in Neuronal Differentiation
In Sox2-del NSC, approximately 1000 genes are downregulated in the undifferentiated
state [8]. We analyzed, by over-representation analysis (ORA), the gene ontology (GO)
terms more significantly enriched among the genes downregulated in Sox2-del cells, as
compared to the total population of genes expressed in WT NSC. Figure S3 shows that the
most significantly enriched GO categories among genes downregulated in Sox2-del cells
include genes whose function is related to various aspects of neuronal differentiation; a list
of these genes is provided in Table S2. This result is somewhat unexpected, and suggests
the intriguing notion that SOX2 might prime, already in undifferentiated cells, the initial
expression of genes related to the neuronal fate.
3.5. CUT&RUN Reveals Broad Genome-Wide Co-Occupancy of SOX2 and the AP1 Complex
in NSC
Our previous results are suggestive of the possibility that SOX2, together with FOS
(and possibly JUN, forming with FOS the AP1 complex) acts to regulate genes important
for NSC differentiation. To test this, we analyzed in detail the CUT&RUN genome-wide
chromatin binding analysis of SOX2, FOS, and JUN previously performed in NSC [9]. We
derived two independent lists of high-confidence binding regions (15.759 for SOX2 and
14.277 for AP1, Figure 4), by considering the peaks obtained with the corresponding antibodies (Figure 4A). Strikingly, we found that when the SOX2 and the AP1 high-confidence
peaks were compared, many of the resulting genomic locations appeared to be shared, indicating possible co-occupancy of several loci, genome-wide, by SOX2 and AP1 (Figure 4C).
SOX2 mediates functional long-range interactions between regulatory regions required
for gene expression [8]. We reasoned that CUT&RUN might detect regulatory regions
that come in physical proximity via looping with the SOX2-bound loci and that not all the
peaks identified are therefore caused by direct SOX2 or AP1 binding to the DNA. Therefore,
we aimed at identifying primary SOX2 and AP1 binding sites by in silico size-selection
of the sub-nucleosomal fraction of the obtained reads (Figure 4B,E; Table S3); this approach was previously shown to enrich for those regions that most likely represent specific
transcription factors footprints [23]. This stringent analytical pipeline yielded a group of
6298 loci that are more likely to be directly bound by both SOX2 and AP1 (Figure 4C,F;
Table S3). Consistently, motif analysis performed on this set of genomic regions displayed
prominent enrichment for SOX proteins, and also increased the statistical confidence in
the identification of the bZIP (leucine zipper, such as FOS and JUN) consensus sequence
(Figure 4D, bottom panel). Taken together, these analyses unearth a previously neglected,
broad genomic interplay between SOX2 and the AP1 complex in NSC.
3.6. The SOX2/AP1 Duet Regulates a Large Fraction of Genes Expressed in NSC
Above, we have derived a set of 6298 genomic regions that are likely bound by both
SOX2 and the AP1 complex in NSC. We next asked whether the observed SOX2/AP1
co-occupancy corresponds to the transcriptional regulation of specific sets of genes in NSC.
We annotated the 6298 common SOX2/AP1 peaks, relating them to specific genes using
GREAT [21], with each gene assigned a basal regulatory domain of a minimum distance
upstream (5 kilobases) and downstream (1 kilobase) of the transcription start site (TSS).
We obtained a list of 5863 genes that are likely regulated by the observed SOX2 and AP1
association (Figure 5A, SOX2/AP1-associated genes). In parallel, we derived a list of
12,933 genes that are expressed in NSC, as they displayed a TPM value above 1 in our RNAseq experiments [8] (Figure 5A, Expressed genes). Of note, a large fraction of 4702 genes,
which corresponds to ca. 36% of all the expressed genes in undifferentiated NSC, are
associated with SOX2 and AP1 occupancy (Figure 5A). Gene ontology (GO) analysis of this
group of genes yielded broad categories which, when ranked from lowest false discovery
rates (FDR), were enriched in terms such as regulation of cellular, developmental, and
metabolic processes (Figure 5B; Table S4). These observations thrust forward the important
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notion that SOX2 and AP1 act together as a functional duet, likely necessary for general
aspects of gene regulation in NSC. Focusing on genes and immediately surrounding regions
(Figure 5C), we note that the observed binding of both SOX2 and AP1 was either on gene
promoters (e.g., Btg2, Gsx1), or within introns (e.g., Lrp4), or within sequences adjacent to
the gene (e.g., Nkx2-2), within the flanking Nkx2-2os region (Figure 5C). Interestingly, the
non-promoter peaks in Map1b, Lrp4, Tmem108, and in the region flanking Nkx2-2 all carry
epigenetic enhancer marks [8]; further, the chromatin region where the Lrp4 intronic peak
and the peak adjacent to Nkx2-2 are located is connected, in ChIA-PET experiments, to the
respective gene promoter by long-range interactions [8]. These results point to a role of12 of 22
FOS (as well as SOX2) at both promoter and enhancer regions.

Figure 4. Genome-wide binding of SOX2 and AP1. CUT&RUN of AP-1 and SOX2. (A) Peaks were called for the SOX2, FOS,
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3.6. The SOX2/AP1 Duet Regulates a Large Fraction of Genes Expressed in NSC
Above, we have derived a set of 6298 genomic regions that are likely bound by both
SOX2 and the AP1 complex in NSC. We next asked whether the observed SOX2/AP1 cooccupancy corresponds to the transcriptional regulation of specific sets of genes in NSC.
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quences adjacent to the gene (e.g., Nkx2-2), within the flanking Nkx2-2os region (Figure
5C). Interestingly, the non-promoter peaks in Map1b, Lrp4, Tmem108, and in the region
flanking Nkx2-2 all carry epigenetic enhancer marks [8]; further, the chromatin region
where the Lrp4 intronic peak and the peak adjacent to Nkx2-2 are located is connected, in
ChIA-PET experiments, to the respective gene promoter by long-range interactions [8].
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These results point to a role of FOS (as well as SOX2) at both promoter and enhancer regions.

Figure 5. SOX2 and AP1 co-regulate a plethora of biological processes. (A) Subnucleosomally enriched co-bound peaks were
annotated using GREAT, and overlayed with all genes expressed in NSC (mean TPM > 1) [8]. (B) Functional enrichments
(biological process, DAVID) were performed on the overlapping genes, and the top 10 hits (rising p-value) are shown. See
also Tables S3 and S4. (C) AP1 and SOX2 co-occupy many loci.

3.7. SOX2 and the AP1 Complex Regulate Genes Involved in Neuronal Differentiation
A prominent feature of the Sox2-del NSC is their strongly defective production of
neurons upon differentiation (Figures 1 and 2). This neuronal “incompetence” is largely
rescued by either Sox2 or Fos overexpression, hinting at the intriguing possibility that
the concerted action of SOX2 and AP1 is relevant for the expression of genes involved
in neuronal differentiation. To test this, we considered the genes that were differentially
regulated in NSC upon Sox2 deletion [8] and their overlap with genes annotated to peaks
using GREAT annotation, and extrapolated a short-list of 340 downregulated genes whose
expression is, by definition, dependent on SOX2 presence (Figure 6A; Table S5). Notably,
this group contains genes that have been previously described as relevant for neuronal differentiation. We compared this list of SOX2 targets with our list of SOX2 and AP1 co-bound
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genes, to determine if they were regulated by SOX2/AP1 interplay, and we found that a
consistent number of them displayed concomitant binding events of SOX2 and AP1 in their
genomic loci. Among these, notable examples are Btg2 [24–26], Lrp4 [27], Map1b [28–30],
Tmem 108 [31,32], Nkx2-2 [33–35], Wnt3 [36], Gli2 [37], Egr2/Egr [38], Plxnb3 [39], Gbx2 [40],
Gsx1 [41,42], Jun [43], Tenm4 [44] (some of them are shown as example in Figure 5B). Strikingly, when these 340 downregulated genes were analyzed using the STRING database,
which matches functional interactions across protein networks by unbiased literature mining [45], we uncovered a SOX2/AP1-centered regulatory network composed of neuronal
players (Figure 6B,C and Figure S4; Table S6). This indicates that SOX2 might
15 of 22 be actively
involved in the regulation of differentiation events by interplay with the AP1 complex.

Figure 6. SOX2 and AP1 co-regulate genes involved in neuronal differentiation. (A) Expressed genes bound by AP1 and
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Sox2 were overlayed
genes
that
arethat
significantly
downregulated
change
2; TPM
> 1) upon
knockout
Sox2 werewith
overlayed
with
genes
are significantly
downregulated (fold
(fold change
> 2;>TPM
> 1) upon
knockout
of Sox2 of Sox2 in
NSC [8] (see also
Table
S5).
(B)
AnS5).
interaction
network
was generated
using
anda gene
a gene
ontology
enrichment was
in NSC
[8] (see
also
Table
(B) An interaction
network
was generated
usingSTRING,
STRING, and
ontology
enrichment
was performed,
showing
genes
with the Neuron
GO:term Neuron
differentiation.
largest
cluster was
was isolated,
andand
in that
performed, showing
34 genes
with34the
GO:term
differentiation.
TheThe
largest
cluster
isolated,
in that cluster
cluster were 18 genes with the GO term neuronal differentiation (see also Table S6). (C) Another gene-interaction network
were 18 genes
with
the GO
term
neuronal
differentiation
(see
Table
S6). by
(C)
Another
gene-interaction network was
was
generated,
which
represents
a putative
regulatory core
of also
players
governed
AP-1
and SOX2.
generated, which represents a putative regulatory core of players governed by AP-1 and SOX2.

Recently, we showed that Fos overexpression in Sox2-del NSC fully rescued their defect in long-term proliferation [9]. As Fos is very highly expressed in NSC, and it is
strongly downregulated in Sox2-del NSC, we proposed a model whereby SOX2 maintains
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Figure 7. A simplified model for the roles of Sox2, Fos, and Socs3 in NSC differentiation.

Figure 7. A simplified model for the roles of Sox2, Fos, and Socs3 in NSC differentiation.
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4.2. FOS Binds, in NSC, to a Large Proportion of Expressed Genes Close to SOX2-Bound Regions
We used CUT&RUN to assay for FOS, JUN (forming the AP1 complex) and SOX2
binding to the chromatin of wild-type NSC. The results clearly showed that FOS, in addition
to binding to some specific targets, often binds to common targets also recognized by SOX2
(36% of all expressed genes, Figure 5). Importantly, a high frequency of FOS binding
together with SOX2 is observed in a fraction of genes that are downregulated in Sox2-del
NSC and are bound by SOX2 in wild-type NSC (Figure 6). This observation supports
the idea that FOS might contribute to the rescue of neuronal differentiation by activating
(at least to some extent) genes that are downregulated in the absence of Sox2. Indeed, it
is interesting that several genes that are known to be essential for correct differentiation
of various neuronal types are among the common FOS/SOX2 targets (Figures 4 and 5
and related references in text); some of these, when mutated, cause brain disease in
humans. We would like to hypothesize that neuronal genes already expressed in NSC
are “primed” by SOX2 and FOS in view of a full activation at more advanced stages of
neuronal differentiation.
The level of FOS expression in NSC is exceedingly high, suggesting broad functions in
these cells. Recent models [46,47] propose that specific “anchor” DNA sequences initially
recruit defined transcription factors. These factors increase the accessibility of specific
chromatin regions, acting as a core around which other factors aggregate in a way that
is independent of DNA sequence. This could occur via protein–protein interactions and
chromatin loops, which might connect several distant regulatory elements. In addition, it
was shown that FOS/JUN selects enhancers together with cell-type-specific transcription
factors by binding to enhancers in the context of nucleosomes, and by recruiting the
SWI/SNF chromatin-remodeling complex to establish an accessible chromatin region [48].
Interestingly, our efforts aimed at identifying the genomic regions that most likely represent
the direct SOX2/AP1 targets displayed prominent enrichment of SOX binding motifs
(Figure 4B). It is tantalizing to hypothesize that, in NSC, SOX2 is responsible for the
recruitment of AP1 on most of the common regulatory regions. SOX2 is, in fact, essential
for maintaining promoter/enhancer loops, and this might recruit distant AP1-bound
regulatory regions in the proximity of promoters [8]. Accordingly, several of the SOX2/AP1
peaks are located in gene-distant or intronic regions (Figures 4 and 5), raising the possibility
that these are neural- or neuronal-specific AP1-dependent enhancers that interact with
gene promoters via SOX2-mediated DNA-looping [8]. This seems to be the case with some
genes shown as examples in Figure 5C, Lrp4, and Nkx2-2.
4.3. SOX Transcription Factors Orchestrate Signalling Pathways by Promiscuous Interactions
The family of SOX transcription factors has been repeatedly implicated in the regulation of signaling cascades relevant for the specification of neural structures. For example,
ectopic activation of Sox2 can specify sensory cell progenitors of the mouse cochlea, similarly to Notch pathway activation, possibly suggesting that neuronal programs might be
activated by redundant mechanisms [49]. Moreover, SOX2 was found to regulate neurogenesis from human neural progenitor cells by inhibiting canonical Wnt signaling [50]. In
this context, SOX2 might antagonize the Wnt pathway to maintain a neurogenic fate [51].
On the other hand, a recent report uncovered a dual role for SOX2, in which high SOX2
displaces nucleosomes to recruit the Wnt effectors TCF/LEF and β-catenin and to maintain
the expression of pluripotency genes, while loss of SOX2 would allow WNT-induced mesodermal differentiation (Blassberg et al., BioRxiv; doi:10.1101/2020.12.29.424684). Notably,
it is precisely during mesoderm formation that one of the best-documented cases of the
SOX-WNT interactions occurs, exemplified by the SOX17 genome-wide co-occupancy with
β-catenin [52]. This indicates that the SOX factors might govern the tissue-specific action of
Wnt signaling not only in embryonic stem cells or neural progenitors, but more in general
during development [53].
Importantly, our work reveals that a previously overlooked joint action between
SOX2 and the AP1 complex, which is an important effector of signaling cascades such
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as the MAPK/ERK/RAS pathway [54], might be a novel constituent for the neuronal
differentiation program. It remains, however, to be elucidated how Fos overexpression
can rescue the loss of Sox2. We speculate that, in the absence of SOX2, other SOX proteins
might “prime” the transcriptional activity of AP1 by tethering FOS (and/or JUN) on the
relevant regulatory regions. Notably, recent reports showed that the sub-family of SOXB1
transcription factors, of which SOX2 is a member together with SOX1 and SOX3, bind to
overlapping sites in neural cells chromatin [55] and act redundantly to maintain naïve
pluripotency in embryonic stem cells [56]. This is additionally supported by the presence
of motifs of other SOX proteins in our high-confidence SOX2 CUT&RUN peaks (Figure 4B,
bottom panel) and might provide a mechanistic explanation of how FOS rescues SOX2
deficiency. Whether other SOXB1 proteins engage in a genome-wide functional interplay
together with AP1 remains to be tested.
4.4. A Network of Interactions Directing Neuronal versus Glial Differentiation
In this work, we describe the opposite roles of FOS, a transcription factor, and of
SOCS3, a modulator of cytokine-dependent signaling, on the differentiation of neural progenitors into neurons and glia, respectively. Both Fos and Socs3 are regulated by SOX2, and
their levels are strongly decreased in Sox2-del cells; both Fos and Socs3, when overexpressed,
rescue long-term proliferation of Sox2-del cells. In addition, FOS activates Socs3 in different cell types, including pro-B lymphocytes, breast cancer cells, and NSC [9,57–60]. The
experiments described here show that FOS, in addition to complementing SOX2 absence
in maintaining long-term self-renewal [9], also contributes to improving neuronal differentiation. Fos overexpression increases (initial) neuronal differentiation at the expense of
glial differentiation (Figure 2). Interestingly, it was reported that the knockout of Fos causes
a neuronal differentiation defect during mouse brain development [61,62]. On the other
hand, Socs3 strongly inhibits glial differentiation (Figure 3). SOCS3 is a negative regulator
of cytokine signaling based on the JAK-STAT pathway; STAT3 eventually activates SOCS3,
which in turn negatively regulates STAT3, attenuating the effect of JAK-STAT activation [60].
Factors such as leukemia inhibitory factor (LIF), BMP2, and others have been implicated
in gliogenesis dependent on the SOCS3-attenuated JAK-STAT pathway [60,63]. Accordingly, the knockout of SOCS3 causes inappropriately increased gliogenesis in vitro and
in vivo [60,63]; conversely, SOCS3 overexpression inhibits astrogliogenesis [59], and LIF
treatment efficiently promotes astrogliogenesis in the absence (knockout) of Socs3 [60,63].
In NSC lacking Sox2 and overexpressing Socs3, both glial and neuronal differentiation are
strongly impaired, due on one side to excess Socs3 expression, which represses gliogenesis,
on the other side to the lack of Sox2 that prevents the differentiation into neurons of the
glial/neuronal bipotent progenitors (Figures 3 and 7). Thus, SOX2 activates two genes, Fos
and Socs3, whose balanced regulation is necessary to define the appropriate differentiation
of neurons versus glia.
Further, SOX2 regulates the expression of JUN, together with that of FOS, which in
turn also binds to the Jun gene (Figure 4), presumably regulating it and creating a virtuous
circle (Figure 7).
Finally, the human Sox2 gene homolog SOX2, together with FOXP2 (whose mutation
causes language impairment), GLI3 (part of the network in Figure 6), RCAN1 (involved in
the pathogenesis of Down’s syndrome) and other genes, belong to a set of genes whose enhancers or promoters harbor modern human single-nucleotide changes that appeared after
the split from the Neanderthal/Denisovan lineage, and have been proposed to contribute
to modern human-specific characteristics [64]. In mice, SOX2 directly binds to FOXP2,
GLI3, and RCAN1 regulatory elements [8], raising the intriguing possibility that changes in
SOX2/AP1 co-binding may contribute to the evolution of human-specific gene regulation.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/10
.3390/cells10071757/s1, Figure S1: Secondary antibody-only control, Figure S2: RT-PCR quantitation
of Sox2, Fos and Socs3 mRNA in WT, Sox2-del and Sox2-del NSC transduced with Sox2, or Fos
or Socs3-expressing lentiviruses. qRT-PCR was performed in triplicate, Figure S3: GO-biological
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process analysis for genes downregulated in undifferentiated Sox2-del NSC, Figure S4: The whole
interaction network from Figure 6, showing the biggest network using MCL 1.1, Table S1: RNA-Seq
Expression Data for WT and Sox2-del NSC at D4 and D11, Table S2: Lists of genes belonging to
each GO term in Figure S2 are given (sheet: enriched gene set GO analysis), Table S3. GREAT
annotation of subnucleosomally enriched peaks shared between SOX2 and AP1 (.xcl file), Table S4.
DAVID Gene Ontology analysis of genes bound by SOX2 and AP1 that are expressed in NSC (.xcl
file), Table S5. Genes bound by SOX2 and AP1 and downregulated in SOX2-deleted NSC (.xcl
file), Table S6. STRING Gene Ontologies for genes bound by SOX2 and AP1 and downregulated in
SOX2-deleted NSC (.xcl file).
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